1. Home
  2. CUE vs SPPL Comparison

CUE vs SPPL Comparison

Compare CUE & SPPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.47

Market Cap

17.6M

Sector

Health Care

ML Signal

HOLD

SPPL

SIMPPLE LTD.

N/A

Current Price

$1.95

Market Cap

18.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
CUE
SPPL
Founded
2014
2016
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.6M
18.2M
IPO Year
2017
2022

Fundamental Metrics

Financial Performance
Metric
CUE
SPPL
Price
$0.47
$1.95
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
4.4M
13.9K
Earning Date
05-11-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
61.11
N/A
EPS
N/A
N/A
Revenue
$27,466,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
195.75
N/A
52 Week Low
$0.17
$1.50
52 Week High
$1.03
$7.00

Technical Indicators

Market Signals
Indicator
CUE
SPPL
Relative Strength Index (RSI) 76.38 41.92
Support Level $0.26 $1.50
Resistance Level $0.85 $3.54
Average True Range (ATR) 0.06 0.27
MACD 0.02 0.03
Stochastic Oscillator 61.27 34.09

Price Performance

Historical Comparison
CUE
SPPL

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.

Share on Social Networks: